SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000078003-20-000022
Filing Date
2020-03-11
Accepted
2020-03-11 19:22:00
Documents
1
Period of Report
2020-03-11

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 8169
  Complete submission text file 0000078003-20-000022.txt   10368
Mailing Address 235 E 42ND ST NEW YORK NY 10017
Business Address 235 E 42ND ST NEW YORK NY 10017 2125732323
PFIZER INC (Reporting) CIK: 0000078003 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-39247 | Film No.: 20706794
SIC: 2834 Pharmaceutical Preparations

Mailing Address 116 HUNTINGTON AVENUE 6TH FLOOR BOSTON MA 02116
Business Address 116 HUNTINGTON AVENUE 6TH FLOOR BOSTON MA 02116 617-206-2020
IMARA Inc. (Issuer) CIK: 0001672619 (see all company filings)

IRS No.: 811523849 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 235 EAST 42ND STREET NEW YORK NY 10017
Business Address 235 EAST 42ND STREET NEW YORK NY 10017 2127332323
Pfizer Ventures (US) LLC (Reporting) CIK: 0001776087 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-39247 | Film No.: 20706795